|By Business Wire||
|May 13, 2014 05:01 AM EDT||
NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ:QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today it is a recipient of the Surescripts White Coat of Quality Award, marking its third time earning this prestigious honor. The White Coat of Quality Award is Surescripts’ highest recognition for software providers that uphold strict standards for clinical quality and best practices in e-prescribing.
Established in 2010 as part of Surescripts’ Quality Management Program, the annual White Coat of Quality Award provides a systematic approach to e-prescription quality. Organizations that follow the program’s rigorous guidelines can mitigate inaccurate, incomplete, or inconsistent e-prescriptions, issues that can result in unintended consequences and costly workflow interruptions to prescribers and pharmacists.
Recipients of the awards are evaluated on the following key requirements:
- Senior leadership commitment to a goal of zero electronic prescription content errors;
- Measurement and reporting of e-prescription content error levels;
- Implementation of software updates to reduce e-prescription content error levels; and
- Communication and training for end-users on how to better utilize their e-prescribing system to reduce errors.
“As a three-time recipient of the Surescripts White Coat of Quality Award, NextGen Healthcare’s dedication to producing quality improvements in e-prescribing is one to be mirrored by others in the industry,” said Ajit Dhavle, Pharm.D. MBA, director of quality management, Surescripts. “We are pleased to recognize all those committed to implementing our proven e-prescribing best practices and who worked hard to earn the White Coat of Quality distinction.”
“As we as a healthcare community continue to strive for excellence, the quality and safety of the care patients are receiving is improving,” said Dr. Sarah Corley, chief medical officer for NextGen Healthcare. “Receiving the White Coat of Quality Award again underscores our commitment to not only applying best practices to the use of e-prescribing technology, but also to continuous quality improvement and training of prescribers. Working closely with Surescripts, we are committed to continuing to improve the quality, efficiency, and accuracy of the e-prescribing experience.”
Surescripts is a nationwide health information network that connects, exchanges, and activates health information between pharmacies, payers, pharmacy benefit managers, physicians, hospitals, health information exchanges and health technology firms. By providing information for routine, recurring and emergency care, Surescripts is committed to saving lives, improving efficiency and reducing the cost of health care for all. For more information, go to www.surescripts.com and follow us at twitter.com/surescripts.
About NextGen Healthcare
NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, connectivity and financial solutions, including revenue cycle management services for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen, Facebook at http://www.facebook.com/NextGenHealthcare or LinkedIn at http://www.linkedin.com/company/nextgen-healthcare-information-systems.
Certain statements in this news release are forward-looking statements within the meaning of the federal securities laws, including but not limited to those statements made by Dr. Sarah Corley related to future collaboration with Surescripts, the Company’s future products and offerings, and developments and trends in the healthcare industry. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company’s expectations and projections. Factors that could cause the anticipated results to differ from those described in the forward-looking statements include the possibility that the products of Cerner or the Company will not achieve or sustain market acceptance; the impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in our software; changing economic, political or regulatory influences in the healthcare industry; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; and general economic conditions. Additional risks and uncertainties are set forth in the Company’s public filings with the U.S. Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. The Company expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.
© 2014 Quality Systems, Inc., Irvine, CA 92612
® marks owned by Quality Systems, Inc.